Florent P.
- Country
- France
- Department
- Oncology
Research Overview
- Phase I Evaluation of MEDI5752 Combined with Stereotactic Radiotherapy in Metastatic Soft Tissue Sarcoma Patients
- Evaluation of Anti-GD2 Antibody-Drug Conjugate M3554 in Patients with Advanced Solid Tumors
- Efficacy and Safety of REGN7508 for Primary Prophylaxis of Cancer-Associated Thrombosis in Patients with Solid Tumors Undergoing Cancer Treatment
Data & Insights
Has run more than one trial at 31 of 130 partner sites.
Specializations
Oncology Research
This investigator specializes in the treatment of metastatic soft tissue sarcoma, focusing on innovative therapeutic approaches for advanced stages of the disease.
- Sarcoma Management
- Metastatic Disease Treatment
The investigator explores treatment modalities incorporating stereotactic radiotherapy for patients with metastatic conditions.
Therapeutic Innovation
Active research interests include the development of combination therapy approaches that integrate targeted treatments with radiation-based interventions.
- Novel Treatment Combinations
- Advanced Therapeutic Strategies
The investigator's work centers on evaluating new therapeutic agents in conjunction with established treatment modalities.
Clinical Applications
Research activities focus on safety assessment and therapeutic efficacy in advanced cancer treatment protocols.
- Patient Safety Evaluation
- Treatment Effectiveness
The investigator examines clinical outcomes in patients receiving innovative therapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.